vs
Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and Synopsys (SNPS). Click either name above to swap in a different company.
Synopsys is the larger business by last-quarter revenue ($2.3B vs $1.4B, roughly 1.6× Option Care Health, Inc.). Synopsys runs the higher net margin — 19.9% vs 3.6%, a 16.3% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs 12.2%). Synopsys produced more free cash flow last quarter ($605.2M vs $130.2M). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs 13.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.
OPCH vs SNPS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.3B |
| Net Profit | $51.8M | $448.7M |
| Gross Margin | 19.0% | 71.0% |
| Operating Margin | 5.9% | 5.4% |
| Net Margin | 3.6% | 19.9% |
| Revenue YoY | 12.2% | 50.6% |
| Net Profit YoY | -3.8% | -59.7% |
| EPS (diluted) | $0.32 | $2.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.3B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.4B | $1.6B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.2B | $1.5B | ||
| Q1 24 | $1.1B | $1.6B |
| Q4 25 | — | $448.7M | ||
| Q3 25 | $51.8M | $242.5M | ||
| Q2 25 | $50.5M | $345.3M | ||
| Q1 25 | $46.7M | $295.7M | ||
| Q4 24 | $60.1M | $1.1B | ||
| Q3 24 | $53.9M | $408.1M | ||
| Q2 24 | $53.0M | $292.1M | ||
| Q1 24 | $44.8M | $449.1M |
| Q4 25 | — | 71.0% | ||
| Q3 25 | 19.0% | 78.1% | ||
| Q2 25 | 19.0% | 80.2% | ||
| Q1 25 | 19.7% | 81.4% | ||
| Q4 24 | 21.3% | 78.3% | ||
| Q3 24 | 20.1% | 80.9% | ||
| Q2 24 | 20.3% | 79.4% | ||
| Q1 24 | 20.8% | 80.0% |
| Q4 25 | — | 5.4% | ||
| Q3 25 | 5.9% | 9.5% | ||
| Q2 25 | 5.8% | 23.5% | ||
| Q1 25 | 5.9% | 17.3% | ||
| Q4 24 | 6.9% | 20.3% | ||
| Q3 24 | 6.7% | 23.6% | ||
| Q2 24 | 6.6% | 22.8% | ||
| Q1 24 | 6.0% | 21.8% |
| Q4 25 | — | 19.9% | ||
| Q3 25 | 3.6% | 13.9% | ||
| Q2 25 | 3.6% | 21.5% | ||
| Q1 25 | 3.5% | 20.3% | ||
| Q4 24 | 4.8% | 74.4% | ||
| Q3 24 | 4.2% | 26.7% | ||
| Q2 24 | 4.3% | 20.1% | ||
| Q1 24 | 3.9% | 27.2% |
| Q4 25 | — | $2.44 | ||
| Q3 25 | $0.32 | $1.50 | ||
| Q2 25 | $0.31 | $2.21 | ||
| Q1 25 | $0.28 | $1.89 | ||
| Q4 24 | $0.36 | $7.13 | ||
| Q3 24 | $0.31 | $2.61 | ||
| Q2 24 | $0.30 | $1.88 | ||
| Q1 24 | $0.26 | $2.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $309.8M | $3.0B |
| Total DebtLower is stronger | $1.2B | $13.5B |
| Stockholders' EquityBook value | $1.4B | $28.3B |
| Total Assets | $3.5B | $48.2B |
| Debt / EquityLower = less leverage | 0.86× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0B | ||
| Q3 25 | $309.8M | $2.6B | ||
| Q2 25 | $198.8M | $14.3B | ||
| Q1 25 | $171.4M | $3.8B | ||
| Q4 24 | $412.6M | $4.1B | ||
| Q3 24 | $483.0M | $2.0B | ||
| Q2 24 | $376.9M | $1.7B | ||
| Q1 24 | $219.5M | $1.3B |
| Q4 25 | — | $13.5B | ||
| Q3 25 | $1.2B | $14.3B | ||
| Q2 25 | $1.1B | $10.1B | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | — | $28.3B | ||
| Q3 25 | $1.4B | $27.6B | ||
| Q2 25 | $1.4B | $9.9B | ||
| Q1 25 | $1.4B | $9.3B | ||
| Q4 24 | $1.4B | $9.0B | ||
| Q3 24 | $1.4B | $7.7B | ||
| Q2 24 | $1.4B | $7.2B | ||
| Q1 24 | $1.4B | $6.7B |
| Q4 25 | — | $48.2B | ||
| Q3 25 | $3.5B | $48.2B | ||
| Q2 25 | $3.4B | $23.8B | ||
| Q1 25 | $3.3B | $13.0B | ||
| Q4 24 | $3.4B | $13.1B | ||
| Q3 24 | $3.4B | $11.6B | ||
| Q2 24 | $3.3B | $11.0B | ||
| Q1 24 | $3.2B | $10.6B |
| Q4 25 | — | 0.48× | ||
| Q3 25 | 0.86× | 0.52× | ||
| Q2 25 | 0.82× | 1.01× | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.74× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $139.4M | $639.7M |
| Free Cash FlowOCF − Capex | $130.2M | $605.2M |
| FCF MarginFCF / Revenue | 9.1% | 26.8% |
| Capex IntensityCapex / Revenue | 0.6% | 1.5% |
| Cash ConversionOCF / Net Profit | 2.69× | 1.43× |
| TTM Free Cash FlowTrailing 4 quarters | $220.7M | $1.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $639.7M | ||
| Q3 25 | $139.4M | $671.0M | ||
| Q2 25 | $90.3M | $275.4M | ||
| Q1 25 | $-7.2M | $-67.5M | ||
| Q4 24 | $36.1M | $562.8M | ||
| Q3 24 | $160.4M | $455.4M | ||
| Q2 24 | $195.7M | $476.6M | ||
| Q1 24 | $-68.8M | $-87.8M |
| Q4 25 | — | $605.2M | ||
| Q3 25 | $130.2M | $632.4M | ||
| Q2 25 | $81.2M | $219.8M | ||
| Q1 25 | $-16.6M | $-108.2M | ||
| Q4 24 | $25.8M | $558.4M | ||
| Q3 24 | $150.7M | $415.4M | ||
| Q2 24 | $185.9M | $438.2M | ||
| Q1 24 | $-74.6M | $-128.2M |
| Q4 25 | — | 26.8% | ||
| Q3 25 | 9.1% | 36.3% | ||
| Q2 25 | 5.7% | 13.7% | ||
| Q1 25 | -1.2% | -7.4% | ||
| Q4 24 | 2.0% | 37.3% | ||
| Q3 24 | 11.8% | 27.2% | ||
| Q2 24 | 15.1% | 30.1% | ||
| Q1 24 | -6.5% | -7.8% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | 0.6% | 2.2% | ||
| Q2 25 | 0.6% | 3.5% | ||
| Q1 25 | 0.7% | 2.8% | ||
| Q4 24 | 0.8% | 0.3% | ||
| Q3 24 | 0.8% | 2.6% | ||
| Q2 24 | 0.8% | 2.6% | ||
| Q1 24 | 0.5% | 2.4% |
| Q4 25 | — | 1.43× | ||
| Q3 25 | 2.69× | 2.77× | ||
| Q2 25 | 1.79× | 0.80× | ||
| Q1 25 | -0.15× | -0.23× | ||
| Q4 24 | 0.60× | 0.51× | ||
| Q3 24 | 2.98× | 1.12× | ||
| Q2 24 | 3.69× | 1.63× | ||
| Q1 24 | -1.54× | -0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
SNPS
| License And Maintenance | $940.7M | 42% |
| Other | $640.0M | 28% |
| Design IP Segment | $407.1M | 18% |
| KR | $236.9M | 11% |
| Sales Based Royalties | $30.1M | 1% |
